Dario de Biase

No ORCID on file · 11 papers in corpus · active 2021-2025

Study types

  • article 8
  • other 2
  • review 1

Condition tags

  • endometriosis 11
article 2025
·doi:10.1016/j.labinv.2024.103295
article 2025
article 2025
article 2025
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1016/j.ijgc.2025.101990

OBJECTIVE: Mesonephric-like adenocarcinoma is a rare, aggressive ovarian cancer subtype, newly classified by the World Health Organization in 2020. This study examines the clinical, ultrasound, pathological features, and survival outcomes o…

other 2025
Translational oncology ·doi:10.1016/j.tranon.2025.102367

BACKGROUND: Endometriosis (EMS) is a chronic, gynecological condition affecting 6-10 % of reproductive-age women. While these lesions are benign, ovarian EMS presents cancer-like features, and can progress to endometriosis-correlated ovaria…

other 2025
Scientific reports ·doi:10.1038/s41598-025-26466-3

Endometriosis (EMS) is a chronic gynecological condition affecting 6-10% of reproductive-age women. These lesions, albeit of benign nature, present cancer-like features, and may progress to epithelial ovarian cancer (EOC) through a multiste…

article 2025
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society ·doi:10.1016/j.ijgc.2025.101634

OBJECTIVE: This study aimed to describe 2 types of endometriosis-associated ovarian cancer: those with transitional elements (atypical endometriosis and borderline tumors) termed endometriosis-correlated or incidental benign endometriosis v…

article 2024
·doi:10.1136/ijgc-2024-esgo.62
article 2024
·doi:10.1136/ijgc-2024-esgo.623
article 2024
·doi:10.1016/j.ejmp.2024.103598
review 2021
Diagnostics ·doi:10.3390/diagnostics11040697

Ovarian carcinomas represent a heterogeneous group of neoplasms consisting of separate entities with distinct risk factors, precursor lesions, pathogenesis, patterns of spread, molecular profiles, clinical course, response to chemotherapy, …